Eurobio Scientific Société anonyme (EPA:ALERS)

France · Delayed Price · Currency is EUR

24.00

+1.20 (5.26%)

Apr 24, 2026, 2:08 PM CET

Revenue by Segment

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Diagnostics and Therapeutics	169.00M	154.95M	130.65M	152.90M	185.32M
Diagnostics and Therapeutics Growth	9.07%	18.60%	-14.55%	-17.49%	-2.04%
Total	169.00M	154.95M	130.65M	152.90M	185.32M
Total Growth	9.07%	18.60%	-14.55%	-17.49%	-2.04%

Revenue by Geography

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Europe (Excluding France)	53.56M	38.79M	21.80M	16.81M
Europe (Excluding France) Growth	38.08%	77.95%	29.70%	109.84%
France	90.84M	82.73M	127.57M	166.83M
France Growth	9.81%	-35.15%	-23.54%	-6.97%
United States and Australia	10.54M	-	-	-
United States	-	9.13M	3.54M	1.68M
United States Growth	-	157.99%	110.29%	-8.64%
Total	154.95M	130.65M	152.90M	185.32M
Total Growth	18.60%	-14.56%	-17.49%	-2.04%

Source: S&P Global Market Intelligence.